Tag: antiemetics and antinauseants market segments

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Antiemetics And Antinauseants Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

The market for antiemetics and antinauseants has shown consistent growth recently. Projections indicate its expansion from $8.48 billion in 2025 to $8.72 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 2.8%. This historical growth can be linked to factors such as a rise in cancer cases, an increase in surgical operations, greater awareness concerning chemotherapy’s adverse effects, the development of hospital and clinic infrastructure, and improvements in antiemetic drug formulations.

The antiemetics and antinauseants market is projected to experience consistent expansion over the upcoming years. It will grow to $10.01 billion in 2030 at a compound annual growth rate (CAGR) of 3.5%. This expansion during the forecast period is driven by factors such as the rising incidence of motion sickness, an expanding global elderly population, increased uptake of personalized medicine, advancements in new antiemetic drug delivery methods, and the broadening of outpatient chemotherapy and palliative care provisions. Key developments expected during this period encompass the evolution of personalized anti-nausea treatments, innovative drug delivery systems, multi-therapy strategies, a growing need for supportive care in chemotherapy, and an increase in treatments for motion sickness and travel-associated conditions.

Get A Free Sample Report With In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Antiemetics And Antinauseants Market Industry Drivers: What’s Behind The Revenue Growth?

The rising prevalence of tuberculosis is projected to fuel the expansion of the antiemetics and antinauseants market. Tuberculosis (TB) is an infectious bacterial illness that predominantly impacts the lungs. Antiemetics and antinauseants are administered to control the nausea and vomiting caused by anti-tuberculosis medications. For instance, the Centers for Disease Control and Prevention, a US-based federal agency, reported a provisional total of 10,347 tuberculosis cases in the United States in 2024, as of March 2025. This corresponds to a rate of 3.0 cases per 100,000 population, representing an increase of approximately 8% when compared with 2023. Therefore, the increased occurrence of tuberculosis is anticipated to stimulate the growth of the antiemetics and antinauseants market.

Antiemetics And Antinauseants Market Segmentation: How Does The Market Break Down By Category?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

#Antiemetics And Antinauseants Market Growth Trends: What’s Shaping The Future Outlook?

Leading companies active in the antiemetic and antinauseant markets are focusing on new product innovations, such as ready-to-use injectables, to streamline treatment and enhance patient compliance. These convenient formulations are designed to offer immediate effectiveness, thereby reducing the time and complexity associated with traditional injectable medications. For instance, in July 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, launched FOCINVEZ, which is the first ready-to-use injectable formulation of fosaprepitant, intended to prevent acute and delayed nausea and vomiting linked to highly emetogenic cancer chemotherapy. This product is provided in a 150 mg/50 mL vial, is free of Polysorbate 80, and does not necessitate reconstitution or dilution, enabling direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older, and it has been assigned a unique J-Code J1434 for reimbursement.

Antiemetics And Antinauseants Market Competitive Overview And Top Companies

Major companies operating in the antiemetics and antinauseants market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

View The Full Antiemetics And Antinauseants Market Report:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Antiemetics And Antinauseants Market Regional Distribution: Which Areas Power Market Growth?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2025. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Antiemetics And Antinauseants Market Value Expansion And Long-Term Growth Outlook

The market for antiemetics and antinauseants has experienced consistent expansion over recent years. Projections indicate an increase from $8.48 billion in 2025 to $8.72 billion in 2026, reflecting a compound annual growth rate (CAGR) of 2.8%. This historical growth has been driven by factors such as a higher prevalence of cancer, a greater number of surgical interventions, enhanced awareness regarding chemotherapy-related adverse effects, the broadening of hospital and clinic facilities, and improvements in the development of antiemetic medications.

The antiemetics and antinauseants market is projected to experience consistent expansion over the coming years, reaching an estimated value of $10.01 billion by 2030, with a compound annual growth rate (CAGR) of 3.5%. This expected growth during the forecast period is driven by factors such as the rising incidence of motion sickness, an expanding elderly population worldwide, a growing focus on personalized medicine, advancements in innovative drug delivery mechanisms for antiemetics, and the broadened reach of outpatient chemotherapy alongside palliative care services. Key trends shaping this period encompass the development of tailored anti-nausea therapies, the introduction of novel drug delivery systems, the application of combination therapy strategies, an heightened emphasis on supportive care for chemotherapy patients, and an increase in treatments related to motion sickness and travel-induced nausea.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Antiemetics And Antinauseants Market Opportunity Drivers: What Is Creating New Revenue Potential?

The rising incidence of tuberculosis is anticipated to boost the expansion of the antiemetics and antinauseants market. Tuberculosis (TB) is a contagious bacterial infection that primarily affects the lungs. Medications designed to prevent or relieve nausea and vomiting are often used to counteract side effects resulting from anti-tuberculosis treatments. For example, in March 2025, the Centers for Disease Control and Prevention, a federal agency in the United States, reported that in 2024, there were 10,347 provisional TB cases nationwide, translating to a rate of 3.0 cases per 100,000 people—an increase of roughly 8% compared to 2023. As a result, the growing prevalence of tuberculosis is expected to drive the antiemetics and antinauseants market forward.

A surge in surgical procedures is set to propel growth within the antiemetics and antinauseants market, driven by a heightened demand for managing postoperative nausea and vomiting. Surgery entails medical interventions where instruments are employed to address injuries, diseases, or health conditions through incisions or repair of internal structures. The increasing frequency of surgeries is largely attributed to a higher prevalence of chronic illnesses requiring operative care. Antiemetic and antinauseant agents are administered during surgeries to minimize or prevent postoperative nausea and vomiting triggered by anesthesia and surgical techniques. In April 2025, the Australian Institute of Health and Welfare, an Australian government organization, noted that public hospitals recorded 778,500 admissions from elective surgery waitlists in 2023–24—a 5.8% increase from the 735,500 admissions in 2022–23. Consequently, the rising volume of surgical procedures is fueling growth in the antiemetics and antinauseants market.

Antiemetics And Antinauseants Market Segment Breakdown: Which Categories Generate The Most Revenue?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

Antiemetics And Antinauseants Market Innovation Trends Driving Future Development

Major players within the antiemetic and antinauseant sectors are actively advancing product innovations—particularly ready-to-use injectables—designed to simplify treatment protocols and improve patient adherence. These prefilled formulations aim to deliver rapid therapeutic effects while minimizing the time and intricacy usually associated with traditional injectable drugs. To illustrate, in July 2024, the US-based pharmaceutical firm Amneal Pharmaceuticals introduced FOCINVEZ, the inaugural ready-to-use injectable version of fosaprepitant, intended to prevent both immediate and delayed nausea and vomiting triggered by highly emetogenic cancer chemotherapy. Supplied in a 150 mg/50 mL vial that is Polysorbate 80‑free, this product eliminates the need for reconstitution or dilution, enabling direct administration. Approved for adult patients and pediatric individuals aged six months and older, FOCINVEZ has been given a dedicated J‑Code (J1434) for billing and reimbursement purposes.

Antiemetics And Antinauseants Market Key Players And Strategic Industry Positioning

Major companies operating in the antiemetics and antinauseants market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Access The Complete Antiemetics And Antinauseants Market Report:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Antiemetics And Antinauseants Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2025. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Antiemetics And Antinauseants Market During The Forecast Period?

The antiemetics and antinauseants market has experienced consistent expansion in recent years. This market is set to increase from $8.48 billion in 2025 to $8.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 2.8%. Historically, this growth can be linked to factors such as a rise in cancer cases, an increase in surgical procedures, heightened awareness of chemotherapy’s side effects, the expansion of hospital and clinic facilities, and advancements in antiemetic drug formulations.

The antiemetics and antinauseants market is projected to experience consistent expansion in the coming years. Its valuation is anticipated to reach $10.01 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 3.5%. This forecasted increase can be linked to a higher incidence of motion sickness, an expanding global elderly population, the increasing embrace of personalized medicine, advancements in new antiemetic drug delivery methods, and the broadening of outpatient chemotherapy and palliative care offerings. Key developments expected during this period involve the creation of personalized anti-nausea treatments, innovative drug delivery systems, combined therapeutic strategies, a growing need for chemotherapy support, and an increase in treatments for motion sickness and travel-related conditions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

Which Drivers Are Supporting The Antiemetics And Antinauseants Market Growth?

The rising incidence of tuberculosis is anticipated to drive the expansion of the antiemetics and antinauseants market. Tuberculosis (TB) is a contagious bacterial illness primarily affecting the respiratory system. Antiemetic and antinauseant drugs are utilized to manage nausea and vomiting resulting from anti-tuberculosis treatments. For example, as reported by the Centers for Disease Control and Prevention, a US federal agency, in March 2025, the United States saw a provisional total of 10,347 tuberculosis cases in 2024, representing a rate of 3.0 cases per 100,000 population, which was an increase of approximately 8% compared with 2023. Consequently, the growing prevalence of tuberculosis is projected to stimulate the growth of the antiemetics and antinauseants market. The growing volume of surgical procedures is anticipated to fuel the expansion of the antiemetic and antinauseant market in the future. Surgery involves medical professionals using instruments to address injuries, illnesses, or conditions by operating on the body or repairing internal structures. The increase in surgical interventions is attributed to the rising incidence of chronic diseases that frequently necessitate operative care. Antiemetic and antinauseant medications are administered during surgeries to avert or alleviate postoperative nausea and vomiting induced by anesthesia and the surgical process itself. For example, the Australian Institute of Health and Welfare, an Australian government body, stated in April 2025 that public hospitals in 2023–24 recorded 778,500 admissions from elective surgery waitlists, indicating a 5.8% increase compared with 735,500 admissions in 2022–23. Consequently, the rising number of surgeries is propelling the growth of the antiemetic and antinauseant market.

Which Segment Classifications Are Used In The Antiemetics And Antinauseants Market Segment Analysis?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

What Trends Are Transforming The Antiemetics And Antinauseants Market?

Leading companies in the antiemetic and antinauseant markets are engaged in developing novel product innovations, such as ready-to-use injectables, aimed at streamlining treatment protocols and improving patient adherence. These convenient formulations are designed to offer immediate efficacy, thereby reducing the time and complexity typically associated with traditional injectable medications. For instance, in July 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, launched FOCINVEZ, which is the first ready-to-use injectable formulation of fosaprepitant, specifically developed to prevent acute and delayed nausea and vomiting linked to highly emetogenic cancer chemotherapy. This product comes in a 150 mg/50 mL vial, is free of Polysorbate 80, and does not necessitate reconstitution or dilution, allowing for direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older, and it has been assigned a unique J-Code (J1434) for reimbursement.

Which Firms Are Contributing To The Antiemetics And Antinauseants Market Ecosystem?

Major companies operating in the antiemetics and antinauseants market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Get The Full Antiemetics And Antinauseants Market Report:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Which Region Is The Largest In The Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2025. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Antiemetics And Antinauseants Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Browse Through More Reports Similar to the Global Antiemetics And Antinauseants Market 2026, By The Business Research Company

Antiemetics And Antinauseants Market Report 2026

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Anticholinergic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Antiemetics And Antinauseants Market Over The Period 2026–2030?

The antiemetics and antinauseants market size has shown steady expansion in recent years. It is projected to increase from $8.48 billion in 2025 to $8.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 2.8%. The expansion observed in the historic period stems from a rise in cancer incidence, an increase in surgical procedures, heightened awareness regarding chemotherapy side effects, the growth of hospital and clinic infrastructure, and advancements in antiemetic drug formulations.

The antiemetics and antinauseants market is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach a value of $10.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.5%. Factors contributing to this growth during the projection period include a rising incidence of motion sickness, an expanding global elderly demographic, increased embrace of personalized medical treatments, advancements in new antiemetic drug delivery methods, and the broadening of outpatient chemotherapy and palliative care offerings. Key trends expected within the forecast timeframe encompass the evolution of personalized anti-nausea therapies, innovative drug delivery mechanisms, integrated combination therapy strategies, an increasing need for supportive care in chemotherapy, and an uptick in treatments for motion sickness and travel-associated conditions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

Which Economic Or Industry Drivers Are Impacting The Antiemetics And Antinauseants Market?

The rising incidence of tuberculosis is anticipated to boost the expansion of the antiemetics and antinauseants market. Tuberculosis (TB) is a contagious bacterial ailment that predominantly affects the lungs. These drugs, antiemetics and antinauseants, are utilized to manage nausea and vomiting that can arise from anti-tuberculosis treatments. For example, data from March 2025 by the Centers for Disease Control and Prevention, a US-based federal agency, indicated that in 2024, the United States recorded a provisional total of 10,347 tuberculosis cases, which translates to a rate of 3.0 cases per 100,000 population. This represented an increase of approximately 8% compared with 2023. Consequently, the growing occurrence of tuberculosis is projected to drive the expansion of the antiemetics and antinauseants market.

How Is The Antiemetics And Antinauseants Market Divided Into Its Major Segments?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

How Are Trends Transforming The Antiemetics And Antinauseants Market Landscape?

Leading companies in the antiemetic and antinauseant markets are concentrating on novel product innovations, such as ready-to-use injectables, aimed at optimizing treatment procedures and boosting patient compliance. These pre-prepared formulations are designed to deliver immediate effectiveness, thereby decreasing the duration and complexity commonly associated with traditional injectable medications. For example, Amneal Pharmaceuticals, a US-based pharmaceutical company, launched FOCINVEZ in July 2024. This product represents the inaugural ready-to-use injectable formulation of fosaprepitant, intended to prevent both acute and delayed nausea and vomiting linked to highly emetogenic cancer chemotherapy. The product is provided in a 150 mg/50 mL vial, is free of Polysorbate 80, and eliminates the need for reconstitution or dilution, allowing for straightforward administration. FOCINVEZ has received approval for use in adults and pediatric patients aged six months and older and has been allocated a specific J-Code (J1434) for reimbursement purposes.

Who Are The Prominent Organizations Shaping The Antiemetics And Antinauseants Market?

Major companies operating in the antiemetics and antinauseants market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Read the full antiemetics and antinauseants market report here:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What Are The Top-Performing Regions Within The Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2025. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Antiemetics And Antinauseants Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Browse Through More Reports Similar to the Global Antiemetics And Antinauseants Market 2026, By The Business Research Company

Antiemetics And Antinauseants Market Report 2026

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Anticholinergic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the antiemetics and antinauseants market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Antiemetics And Antinauseants Market’s size between 2026 and 2030?

The antiemetics and antinauseants market has shown consistent expansion in recent years. It is anticipated to grow from $8.48 billion in 2025 to $8.72 billion in 2026, maintaining a compound annual growth rate (CAGR) of 2.8%. The expansion witnessed in the historical period can be attributed to several factors, including an increase in cancer incidence, a rise in surgical procedures, growing awareness of chemotherapy side effects, the expansion of hospital and clinic infrastructure, and advancements in antiemetic drug formulations.

The antiemetics and antinauseants market size is anticipated to show steady growth over the next few years, expanding to $10.01 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 3.5%. This growth during the forecast period is attributable to the increasing prevalence of motion sickness, the expansion of the global geriatric population, rising adoption of personalized medicine, innovations in novel antiemetic drug delivery systems, and the broadening of outpatient chemotherapy and palliative care services. Noteworthy trends in the forecast period encompass the development of personalized anti-nausea therapies, new drug delivery systems, combination therapy approaches, growing demand for chemotherapy supportive care, and an increase in motion sickness and travel-related treatments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

Which Drivers Are Shaping Strategic Decisions In The Antiemetics And Antinauseants Market?

The expanding occurrence of tuberculosis is anticipated to drive the demand for the antiemetics and antinauseants market. Tuberculosis (TB), an infectious bacterial condition mainly affecting the lungs, often necessitates anti-tuberculosis medications. These medications can induce nausea and vomiting, which antiemetics and antinauseants are used to manage. For instance, data from March 2025, provided by the US-based federal agency, Centers for Disease Control and Prevention, showed that in 2024, the United States recorded a provisional sum of 10,347 tuberculosis cases. This figure represents a rate of 3.0 cases per 100,000 population, marking an approximate 8% rise from 2023. Consequently, the rising prevalence of tuberculosis is projected to boost the growth of the antiemetics and antinauseants market.

What Segment Classifications Make Up The Antiemetics And Antinauseants Market?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

What Long-Term Trends Are Expected To Shape The Future Of The Antiemetics And Antinauseants Market?

Leading companies in the antiemetic and antinauseant markets are focusing on innovative product developments, such as ready-to-use injectables, to enhance treatment efficiency and improve patient adherence. These pre-prepared formulations aim to deliver immediate effectiveness, thereby reducing the time commitment and complexities often associated with conventional injectable medications. For example, in July 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, introduced FOCINVEZ, which is the first ready-to-use injectable formulation of fosaprepitant, developed to prevent both acute and delayed nausea and vomiting linked with highly emetogenic cancer chemotherapy. This product is supplied in a 150 mg/50 mL vial, is free of Polysorbate 80, and requires no reconstitution or dilution, allowing for direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older, and it has been issued a unique J-Code (J1434) for reimbursement.

Which Leading Companies Dominate The Antiemetics And Antinauseants Market Share?

Major companies operating in the antiemetics and antinauseants market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

How Does The Antiemetics And Antinauseants Market Perform Across Major Global Regions?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2025. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Antiemetics And Antinauseants Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Browse Through More Reports Similar to the Global Antiemetics And Antinauseants Market 2026, By The Business Research Company

Antiemetics And Antinauseants Market Report 2026

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Anticholinergic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the antiemetics and antinauseants market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Antiemetics And Antinauseants Market Today And What Will It Reach By 2029?

The antiemetics and antinauseants market has shown consistent expansion in recent times. It is projected to increase from $8.19 billion in 2024 to $8.48 billion in 2025, at a compound annual growth rate (CAGR) of 3.6%. The growth witnessed during the historic period can be attributed to historical branding and market competition, historical treatment preferences, economic conditions, historical global health events, medical advancements and research.

The antiemetics and antinauseants market is projected to experience consistent expansion over the upcoming years. This market is forecast to reach $9.64 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 3.3%. During the forecast period, this expansion is anticipated due to factors such as research and development efforts, economic conditions, competitive market dynamics and industry developments, evolving disease trends, and healthcare policies and regulatory frameworks. Key trends anticipated for this period encompass a heightened emphasis on patient experience, shifts in healthcare policies, a growing consumer inclination towards non-invasive therapies, an increase in chemotherapy and pregnancy-induced nausea cases, and the development of targeted treatments.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What Factors Are Boosting The Antiemetics And Antinauseants Market?

The antiemetics and antinauseants market expands with the increasing prevalence of cancer. Chemotherapy, a widely recommended treatment for cancer, frequently causes side effects such as chemotherapy-induced nausea and vomiting (CINV), which antiemetics can prevent in approximately 60%-70% of patients. For illustration, in April 2024, The American Cancer Society, a non-profit organization headquartered in the United States, projected around 609,000 cancer-related deaths and an estimated 1.9 million new cancer cases identified in the country in 2022. A modest increase in mortality rates is expected in 2024, with an anticipated 620,000 cancer deaths. This rising cancer incidence will escalate the demand for antiemetics and antinauseants, thereby boosting the market’s revenue.

How Is The Antiemetics And Antinauseants Market Categorized By Application, Type, And Region?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

How Are Technological Trends Affecting The Antiemetics And Antinauseants Market Growth?

Major companies in the antiemetic and antinauseant markets are focusing on new product innovations, such as ready-to-use injectables, to streamline treatment processes and enhance patient compliance. These pre-prepared formulations are designed to deliver immediate effectiveness, reducing the time and complexity associated with traditional injectable medications. For instance, in July 2024, Amneal Pharmaceuticals, a US-based specialty pharmaceutical company, launched FOCINVEZ, the first ready-to-use injectable formulation of fosaprepitant, designed to prevent acute and delayed nausea and vomiting linked with highly emetogenic cancer chemotherapy. This product comes in a 150 mg/50 mL vial, is free of Polysorbate 80, and does not require reconstitution or dilution, allowing for direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older and has been assigned a unique J-Code (J1434) for reimbursement.

Who Are The Global Leaders Steering The Antiemetics And Antinauseants Market Forward?

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Browse Through More Reports Similar to the Global Antiemetics And Antinauseants Market 2025, By The Business Research Company

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Smart Pills Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report

Organ On Chip Market 2025

https://www.thebusinessresearchcompany.com/report/organ-on-chip-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Future Growth Projections For The Antiemetics And Antinauseants Market Size?

The market size of antiemetics and antinauseants has been consistently escalating in the past few years. There is an expectation of growth from $8.19 billion in 2024 to $8.48 billion in 2025, experiencing a compound annual growth rate (CAGR) of 3.6%. The past growth is due to factors like historical branding, market competition, preferences in past treatments, economic circumstances, past global health instances, and improvements in medicine and research.

The market for antiemetics and antinauseants is projected to experience consistent growth in the upcoming years, escalating to “$9.64 billion by the year 2029 at a Compound Annual Growth Rate (CAGR) of 3.3%. Factors influencing this prediction of growth for the forecasted period include extensive research and development efforts, economic conditions, competitive market environment, industry dynamics, shifts in disease prevalence, and alterations in healthcare policies and regulations. The forecast period is set to witness notable trends such as enhanced emphasis on patient experiences, modifications in healthcare policies, a consumer preference shift towards non-invasive treatments, an increase in instances of chemotherapy and pregnancy-induced nausea and the advent of targeted therapies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What Are The Primary Factors Supporting The Antiemetics And Antinauseants Market Expansion?

The market for antiemetics and antinauseants is driven upward by a rising rate of cancer prevalence. Nausea and vomiting, related to the chemotherapy often used to treat cancer, are unfortunate side effects of this treatment. However, 60% to 70% of patients can prevent these effects with the use of antiemetic drugs. For example, The American Cancer Society, a U.S-based nonprofit, projected in April 2024 that there were approximately 609,000 deaths due to cancer and an expected 1.9 million new diagnoses of cancer in the U.S. in 2022. A slight increase in mortality rates to an estimated 620,000 deaths is anticipated in 2024. As cancer incidents rise, so will demand for antiemetics and antinauseants, propelling revenue within the market.

How Is The Antiemetics And Antinauseants Market Categorized Across Applications And Types?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

How Are Market Trends Influencing Competition In The Antiemetics And Antinauseants Market?

Leading businesses in the antiemetic and antinauseant industry are focusing on the development of new product innovations like ready-to-use injectables in an effort to enhance treatment procedures and improving patient adherence. These newly developed formulations aim to offer immediate efficacy, simplifying the procedure and reducing the time involved with traditional injectable medications. A notable example is in July 2024, the US-based specialty pharmaceutical firm, Amneal Pharmaceuticals, introduced FOCINVEZ—an injectable format of fosaprepitant, which is designed to combat acute and delayed nausea and vomiting, typically linked to cancer chemotherapy that is highly emetogenic. The product can be found in a 150 mg/50 mL vial, does not contain Polysorbate 80, and eliminates the need for reconstitution or dilution, making it suitable for immediate use. FOCINVEZ is authorized for adults and children aged six months and above, with a distinctive J-Code (J1434) for reimbursement purposes.

Who Are The Global Leaders Steering The Antiemetics And Antinauseants Market Forward?

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What Are The Emerging Regional Trends Driving The Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Antiemetics And Antinauseants Market Valued at Present and by 2029?

The market size for antiemetics and antinauseants has seen consistent growth in the past years. It is projected to increase from $8.19 billion in 2024 to $8.48 billion in 2025, with a compound annual growth rate (CAGR) of 3.6%. Factors contributing to this growth during the historic period include historical branding and competitive market conditions, traditional treatment preferences, economic situation, past global health-related events, as well as advancements in medical research.

In the forthcoming years, the market size of antiemetics and antinauseants is expected to witness consistent expansion. The sector is projected to reach “$9.64 billion by 2029, courtesy of a compound annual growth rate (CAGR) of 3.3%. The surge during the forecast period could be credited to research and development efforts, economic determinants, competitive market landscape, industrial trends, evolving disease patterns, and health policy and regulatory changes. Key trends anticipated during the forecast period encompass enhanced concentration on patient experience, modifications in healthcare policies, a consumer inclination for non-invasive therapies, an upward trend in chemotherapy and pregnancy-associated nausea cases, and the rise of targeted treatment approaches.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

#What Drivers Are Influencing Growth In The Antiemetics And Antinauseants Market?

The market for antiemetics and antinauseants is influenced by the escalating prevalence of cancer. One of the most advised remedies for cancer is chemotherapy, which unfortunately leads to side effects such as chemotherapy-induced nausea and vomiting (CINV). Fortunately, antiemetics have been found to prevent CINV in about 60%-70% of patients. For example, The American Cancer Society, a U.S.-based non-profit organization, estimated in April 2024 that around 609,000 cancer-related deaths occurred and approximately 1.9 million new cancer cases were detected in the country in the year 2022. They projected about 620,000 deaths due to cancer, indicating a slight surge in mortality rates in 2024. This growing occurrence of cancer will boost the need for antiemetics and antinauseants, thereby stimulating market revenue.

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

What Long-Term Trends Are Likely To Affect The Antiemetics And Antinauseants Market?

Leading corporations in the antiemetic and antinauseant industry are focusing on the design of innovative products such as ready-to-use injectables, with the aim of simplifying the therapy process and boosting patient compliance. These ready-to-use solutions are meant to offer quick relief, thus cutting down on the time and complexity usually entailed by conventional injectable treatments. For example, in July 2024, the US-based specialty pharma company Amneal Pharmaceuticals introduced FOCINVEZ, the inaugural ready-to-use injectable variant of fosaprepitant. This product’s purpose is to combat acute and delayed nausea and vomiting that are side effects of intense cancer chemotherapy. Available in a 150 mg/50 mL vial, this Polysorbate 80-free product does not necessitate reconstitution or dilution, facilitating straightforward application. FOCINVEZ, approved for usage in adults and children aged six months upwards, has been allocated a distinct J-code (J1434) for reimbursement purposes.

Which Companies Play A Key Role In The Development Of The Antiemetics And Antinauseants Market?

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What Are The Key Regional Developments Shaping The Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model